4,5-Difluoro-2-methoxybenzonitrile | CAS:425702-28-9

We serve 4,5-Difluoro-2-methoxybenzonitrile CAS:425702-28-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4,5-Difluoro-2-methoxybenzonitrile

Chemical Name:4,5-Difluoro-2-methoxybenzonitrile
CAS.NO:425702-28-9
Synonyms:4,5-Difluoro-2-methoxybenzonitrile
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 251.1±35.0 °C at 760 mmHg
Melting Point 89-90°C
Molecular Formula C8H5F2NO
Molecular Weight 169.128
Flash Point 105.7±25.9 °C
Vapour Pressure 0.0±0.5 mmHg at 25°C
Index of Refraction 1.485
 
Specification:
Appearance:White to light yellow powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 4,5-Difluoro-2-methoxybenzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,5-Difluoro-2-methoxybenzonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,5-Difluoro-2-methoxybenzonitrile Use and application,4,5-Difluoro-2-methoxybenzonitrile technical grade,usp/ep/jp grade.


Related News: International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.methanethiol manufacturer Wuhan’s local transport networks – including bus, subway and ferries – were suspended from 10am on 23 January, and airport and train stations closed to outgoing passengers.N,N-Bis(2-hydroxyethyl)-p-phenylenediamine sulphate supplier In addition, with the increase of environmental protection pressure, nearly one hundred Beijing pharmaceutical companies have gathered in the Bohai Bay, and the raw material drug base in northern China has taken shape.Chroman-4-one vendor The company’s iPSC product platform unites stem cell biology and precision genetic engineering to create renewable master engineered iPSC lines that can be repeatedly used to mass produce cancer-fighting immune cells, replacing the high production costs, weeks of manufacturing time, and complex engineering processes required for current-generation CAR T-cell immunotherapies with an off-the-shelf product that has the potential to reach many more patients.The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.